School of Nursing, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW, Australia.
Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.
BMC Psychol. 2023 Aug 16;11(1):235. doi: 10.1186/s40359-023-01204-4.
Given the increasing number of Hematopoietic Stem Cell Transplantations (HSCT) performed world-wide, the increasing likelihood of survival following HSCT, and the profound physical, psychosocial, and emotional impact of HSCT on survivors, their carers and families, it is important to identify factors that may contribute to or support post-traumatic growth (PTG) after transplant. In this study, we aimed to investigate the prevalence of PTG in an Australian cohort of long-term allogeneic HSCT survivors and describe associations between PTG and relevant clinical, sociodemographic and psychological variables.
This was a large, multi-centre, cross sectional survey of Australian HSCT-survivors inviting all those transplanted in New South Wales between 2000 and 2012. Respondents completed the PTG Inventory (PTGI), the Sydney Post-BMT Survey, FACT-BMT, DASS 21, The Chronic Graft versus Host Disease (GVHD) Activity Assessment-Patient Self-Report (Form B), the Lee Chronic GVHD Symptom Scale, and the Fear of Cancer Recurrence Scale. Data was analysed using independent t-tests, one-way analysis of variance, and pearson's correlations, and hierarchical multiple regression adjusted for potential confounders and to ascertain independent associations of explanatory variables with PTG.
Of 441 respondents, 99% reported some level of PTG with 67% reporting moderate to high levels of PTG. Female gender, younger age, complementary therapy use, anxiety, psychological distress and psychosocial care, and higher quality of life were associated with higher levels of PTG. Importantly, we also found that PTG was not associated with either chronic GVHD or post-HSCT morbidity.
In this study - the largest study of PTG in long-term allogeneic HSCT survivors - we found that growth appears ubiquitous, with 99% of survivors reporting some degree of PTG and 67% reporting moderate-high levels of PTG. Importantly, we found no association with GVHD or chronic physical post-HSCT morbidity, or adverse financial, occupational or sexual impacts. This suggests that it is the necessity for and experience of, HSCT itself that foments personal growth. Accordingly, healthcare professionals should be alert to the profound and wide-ranging impact of HSCT - and the degree to which survivor's may experience PTG. Identifying interventions that may assist HSCT survivors cope and building their resilience is of utmost importance.
鉴于全球范围内进行的造血干细胞移植(HSCT)数量不断增加,HSCT 后患者存活率不断提高,以及 HSCT 对幸存者及其照顾者和家属在身体、心理社会和情感方面产生的深远影响,确定可能促进或支持移植后创伤后成长(PTG)的因素非常重要。在这项研究中,我们旨在调查澳大利亚长期异基因 HSCT 幸存者队列中 PTG 的患病率,并描述 PTG 与相关临床、社会人口学和心理变量之间的关联。
这是一项对澳大利亚 HSCT 幸存者的大型多中心横断面调查,邀请了 2000 年至 2012 年间在新南威尔士州接受移植的所有患者。受访者完成了创伤后成长量表(PTGI)、悉尼移植后调查、FACT-BMT、DASS-21、慢性移植物抗宿主病(GVHD)活动评估-患者自我报告(B 型)、李慢性 GVHD 症状量表和癌症复发恐惧量表。使用独立 t 检验、单因素方差分析和 Pearson 相关分析以及分层多元回归分析数据,调整潜在混杂因素,确定解释变量与 PTG 的独立关联。
在 441 名受访者中,99%的人报告存在一定程度的 PTG,67%的人报告存在中度至高度的 PTG。女性、年龄较小、使用补充疗法、焦虑、心理困扰和心理社会护理以及较高的生活质量与较高水平的 PTG 相关。重要的是,我们还发现 PTG 与慢性 GVHD 或 HSCT 后发病率无关。
在这项研究中-这是对长期异基因 HSCT 幸存者 PTG 的最大研究-我们发现,99%的幸存者报告存在某种程度的 PTG,67%的幸存者报告存在中度至高度的 PTG,表明成长现象普遍存在。重要的是,我们没有发现与 GVHD 或慢性 HSCT 后身体发病率或不良的财务、职业或性影响相关。这表明,HSCT 本身的必要性和经历孕育了个人成长。因此,医疗保健专业人员应该注意到 HSCT 的深远广泛影响,以及幸存者可能经历的 PTG 程度。确定可能有助于 HSCT 幸存者应对并增强其适应力的干预措施至关重要。